Benzoic acid,4-(butylamino)-, 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester (104-31-4)

 Benzonatate (104-31-4), approved by the FDA in 1958, also can be called for Tessalon ; Nonaethyleneglycol monomethyl ether p-n-butylaminobenzoate ; 3,6,9,12,15,18,21,24,27-Nonaoxaoctacos-1-yl 4-(butylamino)benzoate ; Benzoic acid, 4-(butylamino)-, 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester (9CI) ; 4-(Butylamino)benzoic acid 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester ; P-butylaminobenzoic acid w-O-methylnonaethyleneglycol ester .And it can be used for intermediates and fine chemicals in pharmaceuticals. It is a non-narcotic oral antitussive (cough suppressant) with effects that last from 6 to 8 hours. It is sold generically or under the brand name Tessalon Capsules or Tessalon Perles (gelcaps). As potent anesthetic, the medication is usually recommended to be swallowed whole and is believed to work by decreasing the sensitivity of stretch receptors in the lung, reducing the drive to cough after taking a deep breath.It can also be useful as a topical anesthetic for mouth or pharyngeal pain in small doses.